🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Chinese AntiphosPholipid Syndrome cohorT cOllaborative NEtworks

Recruitingn/aAges any - anyAllPeking Union Medical College Hospital
NCT05230017 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by thrombosis and pregnancy morbidity in patients with persistently positive antiphospholipid antibodies (aPLs). However, large-scale research on general population with persistent aPLs has been lacking. This project proposes to establish the first multicenter cohort of patients with persistently positive aPLs in China and conduct a comprehensive clinical phenotyping study. Based on traditional phenotypes of thrombotic and pregnancy events, the focus will be on extra-standard clinical phenotypes and prospective assessment of event risk and prognosis in aPL-positive population. A prospective analysis of extra-standard antibodies will also be conducted to recommend detection criteria for extra-standard antibody application in China and to assess their clinical significance.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * The presence of one or more of the antiphospholipid antibodies (aPL) tested according to the 2006 Sapporo APS clasification criteria, on two or more occasions at least 12 weeks apart: Exclusion Criteria: * Patients refuse to participate; * Unable to be followed.
💊

What it tests

  • Not listed
📍

Where

18 sites
Peking Union Medical College Hospital
Beijing, China
Beijing Shunyi Hospital
Beijing, China
Fujian Medical University Union Hospital
Fuzhou, China
The Third Affiliated Hospital of Guangzhou Medical University
Guangzhou, China
Shenzhen People's Hospital
Shenzhen, China
The Second People's Hospital of Shenzhen
Shenzhen, China
The First Affiliated Hospital of Guangxi Medical University
Nanning, China
The Affilicated Hospital of Inner Mongolia Medical University
Hohhot, China

…and 10 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy